OQS
AVXL icon

Occudo Quantitative Strategies’s Anavex Life Sciences AVXL Stock Holding History

Occudo Quantitative Strategies’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-60,288
Closed -$395K – 799
2023
Q3 		$395K Buy
60,288
+41,208
+216% +$328K 0.05% 574
2023
Q2 		$155K Buy
+19,080
New +$164K 0.02% 888
2022
Q4 		– Sell
-86,158
Closed -$889K – 960
2022
Q3 		$889K Buy
+86,158
New +$909K 0.07% 452

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $1.74B AUM 32.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Occudo Quantitative Strategies's AVXL Position: Q4 2023 in Review

Occudo Quantitative Strategies sold out of Anavex Life Sciences (AVXL) in Q4 2023, closing a stake of 60,288 shares — an estimated $395K sold.

Occudo Quantitative Strategies first reported a position in AVXL in Q3 2022 and held it in 3 quarters. The position peaked at $889K in Q3 2022. 153 funds tracked by Wall St. Rank hold AVXL as of Q4 2023.

  • Occudo Quantitative Strategies reported no remaining Anavex Life Sciences position as of Q4 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 60,288 Anavex Life Sciences shares in Q4 2023, an estimated $395K.
  • Occudo Quantitative Strategies first reported a position in Anavex Life Sciences in Q3 2022 and held it in 3 quarters.
  • Occudo Quantitative Strategies's Anavex Life Sciences position peaked at $889K in Q3 2022.
  • 153 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q4 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.